Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mannatech appoints new CEO

This article was originally published in The Tan Sheet

Executive Summary

Wayne Badovinus is appointed president and CEO of the multilevel dietary supplements marketer. Badovinus' 43-year career in consumer brands includes senior management positions with Eddie Bauer, Williams-Sonoma and Nordstrom, Coppell, Texas-based Mannatech says June 6. He will take over executive duties from Terry Persinger, who will continue on the Mannatech board, the firm says. Mannatech co-founder and chairman Sam Caster resigned as CEO in August 2007 as the firm faced class-action claims that it had caused its stock to trade at inflated levels by failing to adequately monitor how its associates advertised its products (1"The Tan Sheet" Aug. 27, 2007, In Brief). The firm has agreed to pay $11.25 million to settle the allegations (2"The Tan Sheet" March 24, 2008, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel